Provided by Tiger Trade Technology Pte. Ltd.

La Jolla Pharmaceutical

6.22
0.0000
Volume:- -
Turnover:1.66M
Market Cap:155.11M
PE:48.19
High:6.22
Open:6.22
Low:6.22
Close:6.22
52wk High:6.24
52wk Low:3.07
Shares:24.94M
Float Shares:11.49M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1291
EPS(LYR):0.7166
ROE:24.50%
ROA:-1.52%
PB:-2.11
PE(LYR):8.68

Loading ...

Jan 12, 2021

Major Issues Report

8-K - Current report
Jan 04, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 18, 2020

Major Issues Report

8-K - Current report
Nov 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 30, 2020

Major Issues Report

8-K - Current report
Oct 13, 2020

Major Issues Report

8-K/A [Amend] - Current report
Oct 02, 2020

Major Issues Report

8-K - Current report
Sep 17, 2020

Major Issues Report

8-K - Current report
Sep 11, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 18, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 11, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 29, 2020

Major Issues Report

8-K - Current report
Jul 01, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 30, 2020

Major Issues Report

8-K - Current report
Jun 26, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 24, 2020

Major Issues Report

8-K - Current report
Jun 22, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership